Bill Sponsors: LA HB403 | 2023 | Regular Session
Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Text: Latest bill text (Chaptered) [PDF]
Sponsors
| Name | Type | Sponsorship | District | Financial | Encyclopedia | Biography |
|---|---|---|---|---|---|---|
| Representative Chad Brown [D] | Primary | Sponsored Bills | HD-060 | FollowTheMoney | Ballotpedia | VoteSmart |
